Cargando…

LAMC2 as a prognostic biomarker in human cancer: a systematic review and meta-analysis

OBJECTIVES: Accumulating evidence suggested that the laminin γ2 (LAMC2) expression level was upregulated in various cancers. However, the potential prognostic value of LAMC2 in cancers remains unclear. We conducted a meta-analysis to clarify the association of LAMC2 expression with prognosis. DESIGN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Tao, Liu, Jun-Xia, Xie, Juan, Gao, Zhen, Yang, Zhenshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677043/ https://www.ncbi.nlm.nih.gov/pubmed/36396303 http://dx.doi.org/10.1136/bmjopen-2022-063682

Ejemplares similares

LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
por: Ong, Khaa Hoo, et al.
Publicado: (2023)

GPR115 Contributes to Lung Adenocarcinoma Metastasis Associated With LAMC2 and Predicts a Poor Prognosis
por: Wang, Yingjing, et al.
Publicado: (2020)

LAMC1 is a Novel Prognostic Factor and a Potential Therapeutic Target in Gastric Cancer
por: Xi, Dayong, et al.
Publicado: (2022)

Identification of Therapeutic and Prognostic Biomarkers of Lamin C (LAMC) Family Members in Head and Neck Squamous Cell Carcinoma
por: Jiang, Pan, et al.
Publicado: (2020)

LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
por: Kunitomi, Haruko, et al.
Publicado: (2019)

Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis
por: Yu, Tao, et al.
Publicado: (2021)

Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis
por: Naheed, Salma, et al.
Publicado: (2022)

FOXP4-AS1 May be a Potential Prognostic Biomarker in Human Cancers: A Meta−Analysis and Bioinformatics Analysis
por: Zhang, Guangming, et al.
Publicado: (2022)

PLAU and LAMC2 can predict a poor prognosis in patients with HNSCC
por: Guo, Zhi-chen, et al.
Publicado: (2023)

Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis
por: Jiang, Donglei, et al.
Publicado: (2022)

The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis
por: Naheed, Salma, et al.
Publicado: (2019)

Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
por: El Bairi, Khalid, et al.
Publicado: (2021)

Prognostic value of pretreatment serum albumin−globulin ratio in urothelial carcinoma: A systematic review and meta-analysis
por: Xia, Zhongyou, et al.
Publicado: (2022)

Prognostic prediction models for oropharyngeal squamous cell carcinoma (OPSCC): a protocol for systematic review, critical appraisal and meta-analysis
por: Lu, Zhen, et al.
Publicado: (2023)

Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels
por: Rubino, Franco, et al.
Publicado: (2022)

The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis
por: Zhu, Guang, et al.
Publicado: (2021)

Prognostic Value of CD9 in Solid Tumor: A Systematic Review and Meta-Analysis
por: Zeng, Ping, et al.
Publicado: (2021)

Identification of GSN and LAMC2 as Key Prognostic Genes of Bladder Cancer by Integrated Bioinformatics Analysis
por: Yang, Jia-Lian, et al.
Publicado: (2020)

Variants in LAMC3 Causes Occipital Cortical Malformation
por: Qian, Xiaohang, et al.
Publicado: (2021)

Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-Analysis
por: Qian, Shushu, et al.
Publicado: (2020)

The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
por: Hu, Jianyu, et al.
Publicado: (2022)

Prognostic value of dysadherin in cancer: A systematic review and meta-analysis
por: Niinivirta, Aino, et al.
Publicado: (2022)

Prognostic value of Musashi 2 (MSI2) in cancer patients: A systematic review and meta-analysis
por: Jiang, Lin, et al.
Publicado: (2022)

ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
por: Deng, TengFei, et al.
Publicado: (2023)

A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
por: Tong, Tongyu, et al.
Publicado: (2020)

Polo-like kinase 1 as a potential therapeutic target and prognostic factor for various human malignancies: A systematic review and meta-analysis
por: Wang, Ming-Wen, et al.
Publicado: (2022)

Prognostic Impact of Memory CD8(+) T Cells on Immunotherapy in Human Cancers: A Systematic Review and Meta-Analysis
por: Jin, Yao, et al.
Publicado: (2021)

Association of prognostic nutritional index with prognostic outcomes in patients with glioma: a meta-analysis and systematic review
por: Hung, Kuo-Chuan, et al.
Publicado: (2023)

Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis
por: Xie, Jingling, et al.
Publicado: (2022)

LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

Comparing Biomarkers for Predicting Pathological Responses to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Systematic Review and Meta-Analysis
por: Zhao, Fuxing, et al.
Publicado: (2021)

High LAMC1 expression in glioma is associated with poor prognosis
por: Liu, Jian, et al.
Publicado: (2019)

A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery
por: Pallauf, Maximilian, et al.
Publicado: (2022)

Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis
por: Tian, Xiaoling, et al.
Publicado: (2015)

The Prognostic Value of Plasma Cell-Free DNA Concentration in the Prostate Cancer: A Systematic Review and Meta-Analysis
por: Liu, Hongtao, et al.
Publicado: (2021)

Prognostic Value of Pre-Treatment Prognostic Nutritional Index in Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Hao, Jianqi, et al.
Publicado: (2020)

Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations
por: Xiang, Yunhui, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Chen, Xiuqiong, et al.
Publicado: (2021)

Systematic Review With Meta-Analysis: Diagnostic, Prognostic and Clinicopathological Significance of CircRNA Expression in Renal Cancer
por: Wang, Wujun, et al.
Publicado: (2022)

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
por: Yu, Zhaojun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u8db1h7mm3kjstfgup7nu0r2h3